Related Experiment Videos
[Post-radiotherapy cutaneous neuro-endocrine carcinoma]
F Lardy1, C Gautier, S Etesse-Pichon
1Unité de Dermatologie-Cancérologie, Hôpital Pellegrin, Bordeaux.
Annales De Dermatologie Et De Venereologie
|January 1, 1996
Summary
Prior radiotherapy may increase the risk of developing Merkel cell carcinoma (MCC), a rare skin cancer. This case report suggests a potential link between radiation exposure and MCC development, impacting future treatment strategies.
Area of Science:
- Oncology
- Dermatology
- Radiation Oncology
Background:
- Merkel cell carcinoma (MCC), a rare and aggressive cutaneous neuroendocrine carcinoma, has a suspected link to ionizing radiation.
- Previous reports have exceptionally documented MCC development following radiotherapy.
Observation:
- An 86-year-old male received radiotherapy for basal cell carcinoma on his nose.
- Six years post-radiotherapy, he developed an aggressive MCC at the same anatomical site.
Findings:
- MCC developed in irradiated tissue in 2.6% of reported cases with dermatological history, suggesting potential underestimation.
- The latency period between radiotherapy and MCC development can range from 5 to 47 years.
- Similarities in carcinogenic factors (UV, ionizing radiation) for MCC and other skin cancers (basal cell, squamous cell) suggest a common epidermal origin.
Implications:
- The findings suggest MCC may be a radiation-induced tumor, particularly when occurring in previously irradiated areas.
- Clinical management of MCC in patients with a history of radiotherapy should exclude post-operative radiotherapy.
- This association highlights the importance of considering radiation history in MCC diagnosis and treatment planning.